Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 389 (RNA5SP389) is a genomic DNA sequence that is homologous to 5S ribosomal RNA genes but has acquired mutations that prevent it from functioning as a 5S ribosomal RNA. It is classified as a ribosomal RNA pseudogene, meaning it is a nonfunctional relic of a once-active 5S rRNA gene. Pseudogenes like RNA5SP389 are typically not expressed, do not produce biologically active RNA or proteins, and are not associated with known signaling pathways, drug mechanisms, or diseases. These pseudogenes are abundant in the human genome but are not considered therapeutic targets. If your inquiry intended a different, functional RNA or therapeutic target, please specify, as this entry does not fulfill typical criteria for a target relevant to pharmacology or clinical biomarker development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 389 (RNA5SP389).